Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Emma Kutvonen"'
Autor:
Victor Cervera-Carrascon, Dafne C.A. Quixabeira, Riikka Havunen, Joao M. Santos, Emma Kutvonen, James H.A. Clubb, Mikko Siurala, Camilla Heiniö, Sadia Zafar, Teija Koivula, Dave Lumen, Marjo Vaha, Arturo Garcia-Horsman, Anu J. Airaksinen, Suvi Sorsa, Marjukka Anttila, Veijo Hukkanen, Anna Kanerva, Akseli Hemminki
Publikováno v:
Molecular Therapy: Oncolytics, Vol 17, Iss , Pp 47-60 (2020)
Despite some promising results, the majority of patients do not benefit from T cell therapies, as tumors prevent T cells from entering the tumor, shut down their activity, or downregulate key antigens. Due to their nature and mechanism of action, onc
Externí odkaz:
https://doaj.org/article/fe9dd0679d8f4d2392893fc0b76cdcb8
Autor:
Leena J. Laine, Jenni H.E. Mäki-Jouppila, Emma Kutvonen, Pekka Tiikkainen, Thomas K.M. Nyholm, Jerry F. Tien, Neil T. Umbreit, Ville Härmä, Lila Kallio, Trisha N. Davis, Charles L. Asbury, Antti Poso, Gary J. Gorbsky, Marko J. Kallio
Publikováno v:
Oncoscience
Hec1 (Highly expressed in cancer 1) resides in the outer kinetochore where it works to facilitate proper kinetochore-microtubule interactions during mitosis. Hec1 is overexpressed in various cancers and its expression shows correlation with high tumo
Autor:
Dafne Carolina Alves Quixabeira, Camilla Heiniö, Riikka Havunen, Marjukka Anttila, Veijo Hukkanen, Suvi Sorsa, James H.A. Clubb, Dave Lumen, Mikko Siurala, Victor Cervera-Carrascon, Sadia Zafar, Anu J. Airaksinen, Anna Kanerva, Akseli Hemminki, Emma Kutvonen, Arturo Garcia-Horsman, Teija Koivula, Joao Manuel Santos, Marjo Vaha
Publikováno v:
Molecular therapy oncolytics
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 17, Iss, Pp 47-60 (2020)
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 17, Iss, Pp 47-60 (2020)
Despite some promising results, the majority of patients do not benefit from T cell therapies, as tumors prevent T cells from entering the tumor, shut down their activity, or downregulate key antigens. Due to their nature and mechanism of action, onc
Autor:
Marita Högberg, Linda Rickardson, Marko J. Kallio, Emma Kutvonen, Stefan Rehnmark, Satu Orasniemi
Publikováno v:
Drug Design, Development and Therapy
Linda Rickardson,1 Emma Kutvonen,2 Satu Orasniemi,2 Marita Högberg,1 Marko J Kallio,2,3 Stefan Rehnmark1 1Noviga Research AB, Södertälje, Sweden; 2Department of Physiology, Institute of Biomedicine, University of Turku, 3Centre for Biotechnology,